Skip to content

proSA® FX993TRecalls & reported problems

Christoph Miethke GmbH & Co. KG · PROSA WITH PROGAV 2.0 A.DISTAL CATHETER · Class 2 · Implant

All models of proSA (17)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 04041906138448), received between Aug 27, 2021 and Oct 5, 2021 — classified as 2 injuries.

The most frequently reported specific device problem is “Infusion or Flow Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Infusion or Flow Problem1
  • Mechanical Problem1

Patient problems

  • Hydrocephalus2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 5, 2021Infusion or Flow Problem; Infusion or Flow Problem

    IT WAS REPORTED THAT THERE WAS AN ISSUE WITH FX993T - PROSA WITH PROGAV 2.0 A.DISTAL CATHETER. ACCORDING TO THE COMPLAINANT A PROSA VALVE WAS BELIEVED TO BE OVERDRAINAGE. THE PATIENT WAS ORIGINALLY IMPLANTED ON AN UNSPECIFIED DATE. THE VALVE WAS EXPLANTED AND RETURNED TO THE MANUFACTURER FOR EVALUATION. FURTHER DETAILS WERE NOT PROVIDED.

    Patient problems: Hydrocephalus

    MAUDE report 12579610 ↗
  • InjuryAug 27, 2021Mechanical Problem; Mechanical Problem

    ACCORDING TO THE COMPLAINANT A PROSA WITH PROGAV 2.0 HAD A MALFUNCTION POSTOPERATIVELY. THE PATIENT WAS ORIGINALLY IMPLANTED ON AN UNKNOWN DATE. THE VALVE IN QUESTION (PROGAV 2.0) WAS SET AND PRESSURE VERIFIED TO ENSURE CORRECTNESS. THE PATIENT RETURNED TO THE HOSPITAL MULTIPLE TIMES DUE TO HEADACHE, NAUSEA ETC. THE DOCTORS RESET THE PRESSURE AND IN EVERY INSTANCE THE VALVE ADJUSTED ITSELF. FINALLY, THE VALVE WAS EXPLANTED AND RETURNED TO THE MANUFACTURER FOR EVALUATION. THE NEW VALVE WAS WITHOUT ISSUES. FURTHER DETAILS WERE NOT PROVIDED.

    Patient problems: Hydrocephalus

    MAUDE report 12377945 ↗

Other Shunt, central nervous system and components devices

All Shunt, central nervous system and components devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page